BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$53.31
-0.92%
Mkt Cap $10.50B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 23, 2026 | $833.73M | $874.57M | +4.90% | $0.17 | -$0.24 | -241.68% | — | — |
| Q4 2025 Oct 27, 2025 | $823.46M | $776.13M | -5.75% | -$0.15 | $0.12 | +180.00% | — | — |
| Q3 2025 Aug 4, 2025 | $761.95M | $825.41M | +8.33% | $0.86 | $1.44 | +67.25% | — | — |
| Q2 2025 May 1, 2025 | $762.44M | $745.14M | -2.27% | $0.94 | $1.13 | +20.21% | — | — |
| Q1 2025 Feb 19, 2025 | $712.30M | $738.22M | +3.64% | $0.54 | $0.92 | +70.37% | — | — |
| Q4 2024 Oct 29, 2024 | $712.35M | $745.74M | +4.69% | $0.78 | $0.91 | +16.67% | — | — |
| Q3 2024 Aug 5, 2024 | $663.98M | $708.66M | +6.73% | $0.36 | $0.96 | +168.31% | — | — |
| Q2 2024 Apr 24, 2024 | $651.83M | $648.83M | -0.46% | $0.31 | $0.71 | +127.71% | — | — |
| Q1 2024 Feb 22, 2024 | $636.67M | $646.21M | +1.50% | $0.44 | $0.49 | +11.36% | — | — |
| Q4 2023 Nov 1, 2023 | $636.24M | $585.97M | -7.90% | $0.46 | $0.46 | +0.00% | — | — |
| Q3 2023 Jul 31, 2023 | $595.23M | $594.60M | -0.11% | $0.47 | $0.54 | +14.89% | — | — |
| Q2 2023 Apr 26, 2023 | $598.86M | $592.95M | -0.99% | $0.43 | $0.60 | +39.53% | — | — |
| Q1 2023 Feb 27, 2023 | $537.62M | $537.54M | -0.02% | -$0.07 | $0.36 | +614.29% | — | — |
| Q4 2022 Oct 26, 2022 | $518.45M | $505.34M | -2.53% | $0.37 | $0.45 | +21.62% | — | — |
| Q3 2022 Aug 3, 2022 | $520.20M | $533.80M | +2.61% | $0.43 | $0.59 | +37.21% | — | — |
| Q2 2022 Apr 27, 2022 | $510.95M | $519.36M | +1.64% | $0.38 | $0.55 | +44.74% | — | — |
| Q1 2022 Feb 23, 2022 | $442.38M | $449.81M | +1.68% | $0.03 | $0.03 | +0.40% | — | — |
| Q4 2021 Oct 27, 2021 | $436.53M | $408.74M | -6.37% | $0.11 | $0.18 | +63.64% | — | — |
| Q3 2021 Jul 28, 2021 | $437.06M | $501.69M | +14.79% | $0.30 | $0.53 | +76.67% | — | — |
| Q2 2021 Apr 29, 2021 | $447.62M | $486.03M | +8.58% | $0.32 | $0.56 | +75.00% | — | — |